We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+52.12%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$2.58B
AUM Growth
+$1.06B
Cap. Flow
+$1.07B
Cap. Flow %
41.35%
Top 10 Hldgs %
67.03%
Holding
812
New
224
Increased
195
Reduced
131
Closed
143

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$211M
2
NVDA icon
NVIDIA
NVDA
+$146M
3
META icon
Meta Platforms (Facebook)
META
+$111M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$42.4M
5
AAPL icon
Apple
AAPL
+$35.7M

Top Sells

Rank Stock Value
1
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$33M
2
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$30.3M
3
IMCR icon
Immunocore
IMCR
+$28.5M
4
SIRI icon
SiriusXM
SIRI
+$26.6M
5
IMO icon
Imperial Oil
IMO
+$24.7M

Sector Composition

Rank Sector Weight
1 Financials 29.84%
2 Technology 29.38%
3 Healthcare 23.72%
4 Communication Services 6.1%
5 Energy 1.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEXX icon
701
Lexaria Bioscience
LEXX
$9.07M
– –
-17,088
Closed -$320K
MLECW icon
702
Moolec Science SA Warrant
MLECW
$180K
– –
-20,174
Closed -$443
NBIX icon
703
Neurocrine Biosciences
NBIX
$16.8B
– –
-18,668
Closed -$2.46M
NNAVW
704
DELISTED
NextNav Inc Warrant
NNAVW
– –
-27,980
Closed -$20.1K
ORCL icon
705
Oracle
ORCL
$435B
– –
-53,863
Closed -$5.68M
PCVX icon
706
Vaxcyte
PCVX
$8.67B
– –
-38,092
Closed -$2.39M
PG icon
707
Procter & Gamble
PG
$340B
– –
-3,141
Closed -$460K
QETA icon
708
Quetta Acquisition Corp
QETA
– –
-23,847
Closed -$241K
RIVN icon
709
Rivian
RIVN
$23.7B
– –
-68,000
Closed -$1.6M
FLNA
710
Filana Therapeutics
FLNA
$48.2M
– –
-500,000
Closed -$11.3M
SGHC icon
711
SGHC Ltd
SGHC
$6.55B
– –
-10,000
Closed -$31.7K
BNKK
712
Bonk Inc
BNKK
$8.48M
– –
-571
Closed -$70.2K
SPKL
713
Spark I Acquisition Corp
SPKL
$101M
– –
-86,664
Closed -$879K
SRPT icon
714
Sarepta Therapeutics
SRPT
$1.81B
– –
-17,012
Closed -$1.64M
SRZNW icon
715
Surrozen Inc Warrant
SRZNW
$8.86K
– –
-18,190
Closed -$352
TEX icon
716
Terex
TEX
$7.58B
– –
-40,202
Closed -$2.31M
TNGX icon
717
Tango Therapeutics
TNGX
$4.51B
– –
-10,000
Closed -$99K
UTHR icon
718
United Therapeutics
UTHR
$22.7B
– –
-9,342
Closed -$2.05M
UUUU icon
719
Energy Fuels
UUUU
$3.57B
– –
-60,000
Closed -$431K
WDC icon
720
Western Digital
WDC
$151B
– –
-10,016
Closed -$396K
XLE icon
721
State Street Energy Select Sector SPDR ETF
XLE
$39.3B
– –
-787,204
Closed -$33M
AIRJ
722
Montana Technologies Corp
AIRJ
$429M
– –
-715,000
Closed -$7.68M
BNAI
723
Brand Engagement Network
BNAI
$95.7M
– –
-15,000
Closed -$1.59M
GCTS
724
GCT Semiconductor Holding
GCTS
$225M
– –
-191,096
Closed -$2.02M
SDST
725
Stardust Power Inc
SDST
$7.27M
– –
-20,000
Closed -$2.21M
27 28
29
30 31

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2024 Portfolio in Review

As of Q1 2024, Cowen and Company held 812 positions worth $2.58B, up 69% from $1.52B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $1.07B of net new capital in Q1 2024, opening 224 new positions and adding to 195 existing holdings. Its largest new stake was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, an estimated $30.3M trimmed.

  • Cowen and Company's largest Q1 2024 buy was Protagonist Therapeutics: 1,557,636 shares worth $45.1M.
  • Cowen and Company added most to Coinbase in Q1 2024, an estimated $211M increase.
  • Cowen and Company's biggest Q1 2024 reduction was Screaming Eagle Acquisition Corp. Class A Ordinary Shares, cutting an estimated $30.3M.
  • Cowen and Company fully exited State Street Energy Select Sector SPDR ETF in Q1 2024, selling an estimated $33M.
  • Cowen and Company's ten largest holdings make up 67% of its $2.58B portfolio in Q1 2024.
  • Cowen and Company opened 224 new positions and closed 143 in Q1 2024.
  • Cowen and Company's portfolio value rose 69% quarter-over-quarter to $2.58B.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.